Resiliency Intervention for Patients With ALS and Their Care-Partners
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
The purpose of this study is to pilot a resiliency and coping intervention for persons recently diagnosed with Amyotrophic Lateral Sclerosis (ALS) and their primary informal caregivers. The data investigators gather in this study will be used to further refine our intervention.
Eligibility criteria
Qualifiers
recent (within ~2 months) of first appointment at Healey Center for diagnosis of ALS documented in Epic (based on recommendations from neurologists)
ability to understand the study and research protocol as determined by a standardized teach-back method of assessment
ability to communicate by writing, speaking, or assistive communication device
English speaking adults
Disqualifiers
patient with ALS with comorbid terminal diagnosis or severe mental health disorder that limits ability to participate (by self-report, as determined by our clinical team);
cognitive disorder that limits ability to participate (per neurologist)
inability or unwillingness to use live video technology (will teach any dyads who have low technology literacy how to use live video technology)
Trial design
Treatments tested in this trial
- Resilient Together ALS
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov